The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World

(2016) Mehmet Sayiner et al.   Clinics in Liver Disease

Hepatocellular carcinoma in noncirrhotic livers is associated with steatosis rather than steatohepatitis

(2016) Suzanne van Meer et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality

(2016) Zobair Younossi et al.   GASTROENTEROLOGY

Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL)

(2016) Pegah Golabi et al.   Health and Quality of Life Outcomes

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

(2016) Fabio Piscaglia et al.   HEPATOLOGY

The Natural Course of Non-Alcoholic Fatty Liver Disease

(2016) Luis Calzadilla Bertot et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without Cirrhosis

(2016) Mehmet Sayiner et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

(2016) Giovanni Targher et al.   JOURNAL OF HEPATOLOGY

Epidemiology and natural history of non-alcoholic fatty liver disease

(2016) Yousef Fazel et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection

(2015) Z. M. Younossi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Cost-effectiveness of Interferon-free therapy for Hepatitis C in Germany - an application of the efficiency frontier approach

(2015) Christian Gissel et al.   BMC INFECTIOUS DISEASES

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

(2015) Siddharth Singh et al.   Clinical Gastroenterology and Hepatology

Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States

(2015) Robert J. Wong et al.   GASTROENTEROLOGY

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009

(2015) Zobair M. Younossi et al.   HEPATOLOGY

Trends in Outpatient Resource Utilizations and Outcomes for Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease

(2015) Zobair M. Younossi et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease

(2015) Zobair M. Younossi et al.   PHARMACOECONOMICS

Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C

(2014) H. Leleu et al.   JOURNAL OF VIRAL HEPATITIS

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

(2014) Peter J. Neumann et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Impact Of Nice’s End-Of-Life Threshold On Patient Access To New Cancer Therapies In England And Wales

(2014) G. Stewart et al.   VALUE IN HEALTH

Anthropometric and Clinical Factors Associated with Mortality in Subjects with Nonalcoholic Fatty Liver Disease

(2012) Munkhzul Otgonsuren et al.   DIGESTIVE DISEASES AND SCIENCES

A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C

(2011) Jules L. Dienstag et al.   HEPATOLOGY

Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality

(2011) Zobair M. Younossi et al.   HEPATOLOGY

Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection

(2011) Priscilla C Hsu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection

(2010) Brad Q. Starley et al.   HEPATOLOGY

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

(2010) Mustafa S. Ascha et al.   HEPATOLOGY

Calibrating Models in Economic Evaluation

(2010) Tazio Vanni et al.   PHARMACOECONOMICS

Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Noreen Hossain et al.   Clinical Gastroenterology and Hepatology

Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease

(2008) Jeffrey B. Schwimmer et al.   CIRCULATION

Long-term improvement in health-related quality of life after orthotopic liver transplantation

(2008) Amy A. Dan et al.   LIVER TRANSPLANTATION

Systematic Review: Health-State Utilities in Liver Disease: A Systematic Review

(2008) David J. McLernon et al.   MEDICAL DECISION MAKING